These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32743577)
1. Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2. Onabajo OO; Banday AR; Yan W; Obajemu A; Stanifer ML; Santer DM; Florez-Vargas O; Piontkivska H; Vargas J; Kee C; Tyrrell DLJ; Mendoza JL; Boulant S; Prokunina-Olsson L bioRxiv; 2020 Jul; ():. PubMed ID: 32743577 [TBL] [Abstract][Full Text] [Related]
2. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Onabajo OO; Banday AR; Stanifer ML; Yan W; Obajemu A; Santer DM; Florez-Vargas O; Piontkivska H; Vargas JM; Ring TJ; Kee C; Doldan P; Tyrrell DL; Mendoza JL; Boulant S; Prokunina-Olsson L Nat Genet; 2020 Dec; 52(12):1283-1293. PubMed ID: 33077916 [TBL] [Abstract][Full Text] [Related]
3. Regulation of IFNα-induced expression of the short ACE2 isoform by ULK1. Perez RE; Saleiro D; Ilut L; Schiltz GE; Eckerdt F; Fish EN; Platanias LC Mol Immunol; 2022 Jul; 147():1-9. PubMed ID: 35489289 [TBL] [Abstract][Full Text] [Related]
4. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform. Mpekoulis G; Frakolaki E; Taka S; Ioannidis A; Vassiliou AG; Kalliampakou KI; Patas K; Karakasiliotis I; Aidinis V; Chatzipanagiotou S; Angelakis E; Vassilacopoulou D; Vassilaki N PLoS One; 2021; 16(6):e0253458. PubMed ID: 34185793 [TBL] [Abstract][Full Text] [Related]
5. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
6. The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults. Oliveto G; Scagnolari C; Frasca F; Sorrentino L; Matera L; Nenna R; Viscido A; Scordio M; Petrarca L; Maria Zicari A; Gentilini E; D'Ettorre G; Ceccarelli G; Midulla F; Antonelli G; Pierangeli A Cytokine; 2022 Oct; 158():155997. PubMed ID: 35969900 [TBL] [Abstract][Full Text] [Related]
7. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites. Williams TL; Strachan G; Macrae RGC; Kuc RE; Nyimanu D; Paterson AL; Sinha S; Maguire JJ; Davenport AP Sci Rep; 2021 Dec; 11(1):24336. PubMed ID: 34934117 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway. Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802 [TBL] [Abstract][Full Text] [Related]
9. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection. Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Ziegler CGK; Allon SJ; Nyquist SK; Mbano IM; Miao VN; Tzouanas CN; Cao Y; Yousif AS; Bals J; Hauser BM; Feldman J; Muus C; Wadsworth MH; Kazer SW; Hughes TK; Doran B; Gatter GJ; Vukovic M; Taliaferro F; Mead BE; Guo Z; Wang JP; Gras D; Plaisant M; Ansari M; Angelidis I; Adler H; Sucre JMS; Taylor CJ; Lin B; Waghray A; Mitsialis V; Dwyer DF; Buchheit KM; Boyce JA; Barrett NA; Laidlaw TM; Carroll SL; Colonna L; Tkachev V; Peterson CW; Yu A; Zheng HB; Gideon HP; Winchell CG; Lin PL; Bingle CD; Snapper SB; Kropski JA; Theis FJ; Schiller HB; Zaragosi LE; Barbry P; Leslie A; Kiem HP; Flynn JL; Fortune SM; Berger B; Finberg RW; Kean LS; Garber M; Schmidt AG; Lingwood D; Shalek AK; Ordovas-Montanes J; ; Cell; 2020 May; 181(5):1016-1035.e19. PubMed ID: 32413319 [TBL] [Abstract][Full Text] [Related]
11. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins. Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients. Bitossi C; Frasca F; Viscido A; Oliveto G; Scordio M; Belloni L; Cimino G; Pietropaolo V; Gentile M; d'Ettorre G; Midulla F; Trancassini M; Antonelli G; Pierangeli A; Scagnolari C Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33401565 [TBL] [Abstract][Full Text] [Related]
13. Interferon-regulated genetic programs and JAK/STAT pathway activate the intronic promoter of the short ACE2 isoform in renal proximal tubules. Jankowski J; Lee HK; Wilflingseder J; Hennighausen L bioRxiv; 2021 Jan; ():. PubMed ID: 33501441 [TBL] [Abstract][Full Text] [Related]
14. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Blume C; Jackson CL; Spalluto CM; Legebeke J; Nazlamova L; Conforti F; Perotin JM; Frank M; Butler J; Crispin M; Coles J; Thompson J; Ridley RA; Dean LSN; Loxham M; Reikine S; Azim A; Tariq K; Johnston DA; Skipp PJ; Djukanovic R; Baralle D; McCormick CJ; Davies DE; Lucas JS; Wheway G; Mennella V Nat Genet; 2021 Feb; 53(2):205-214. PubMed ID: 33432184 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage. Sui Y; Li J; Venzon DJ; Berzofsky JA Front Immunol; 2021; 12():658428. PubMed ID: 34149696 [TBL] [Abstract][Full Text] [Related]
17. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Gkogkou E; Barnasas G; Vougas K; Trougakos IP Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223 [TBL] [Abstract][Full Text] [Related]
18. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993 [TBL] [Abstract][Full Text] [Related]
19. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis. Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743 [TBL] [Abstract][Full Text] [Related]
20. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? Scagnolari C; Bitossi C; Viscido A; Frasca F; Oliveto G; Scordio M; Petrarca L; Mancino E; Nenna R; Riva E; De Vito C; Midulla F; Antonelli G; Pierangeli A Cytokine; 2021 Apr; 140():155430. PubMed ID: 33508651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]